Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phrase "Copper-dependent catalytic reactions" refers not to a single molecular target or receptor, but to a broad class of enzymes whose catalytic activity depends on copper ions. These copper-dependent metalloenzymes are found throughout nature and are responsible for a wide array of biological processes, including oxidation–reduction (redox) reactions, electron transfer, oxygen transport, oxygenation, halogenation, and peptide side-chain cross-linking[6][1][2][5]. Well-characterized classes include oxidases, such as catechol oxidases, and more novel families, such as DUF3328-domain halogenases and BURP-domain peptide cyclases, all of which use copper ions in their active sites to catalyze challenging chemical transformations[1][2][7][5]. The diversity of this group and its involvement in fundamental biochemical reactions make "Copper-dependent catalytic reactions" a functional description, not a unique target, and thus it would not be considered a canonical drug target or biomarker itself. Instead, individual copper-dependent enzymes (for example, laccase, tyrosinase, peptidylglycine alpha-amidating monooxygenase, or DUF3328-domain halogenase) would be considered drug targets only in specific biological contexts[6][1][2][3][5][7].
Redox catalysis via copper ion(s) at the active site; Oxygen activation; Substrate oxidation or halogenation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Copper-dependent metalloenzyme.